A randomized, controlled, multicenter clinical trial of Fruquintinib combined with TAS-102 with Fruquintinib in the treatment of advanced metastatic colorectal cancer with standard treatment failure
收藏NIAID Data Ecosystem2026-03-12 收录
下载链接：
https://www.omicsdi.org/dataset/ecrin-mdr-crc/2707127
下载链接
链接失效反馈官方服务：
资源简介：
Interventions: Experimental group:Give fruquintinib combined with TAS-102;Control Group:fruquintinib
Primary outcome(s): Progression-free survival
Study Design: Parallel
创建时间：
2021-09-15
